Variables | Late-onset SLE (N = 62) | Early-onset SLE (N = 124) | p value |
---|---|---|---|
Female, n (%) | 54 (87.1) | 114 (91.9) | 0.303 |
Age at diagnosis in years, mean (95% CI) | 56.3 (55.1–57.5) | 30.9 (29.3–32.6) |  |
Year of diagnosis | Â | Â | 0.962 |
1990–1999, n (%) | 2 (3.0) | 5 (4.0) |  |
2000–2009, n (%) | 24 (39.0) | 47 (38.0) |  |
2010–2020, n (%) | 36 (58.0) | 72 (58.0) |  |
Underlying disease | Â | Â | Â |
Hypertension, n (%) | 18 (29.0) | 1 (0.8) | < 0.001 |
Diabetes mellitus, n (%) | 4 (6.5) | 0 | 0.012 |
Dyslipidemia, n (%) | 4 (6.5) | 0 | 0.012 |
Chronic kidney disease, n (%) | 3 (4.8) | 0 | 0.036 |
Cerebrovascular disease, n (%) | 4 (6.5) | 0 | 0.012 |
Malignancy, n (%) | 0 | 3 (2.4) | 0.552 |
Duration of follow-up in years, mean (95% CI)a | 4.4 (3.4–5.6) | 6.3 (5.3–7.3) | 0.019 |